See every side of every news story
Published loading...Updated

New Oral Gene Therapy Made Possible by Colorectal Cancer Findings

Summary by Inside Precision Medicine
A study reports a discovery that opens up a new path into treating colorectal cancer (CRC), which is notoriously resilient, with chemoresistance and immunosuppression often standing in the way of effective treatments. Wuhan University scientists identified the mitochondrial protein TRAP1 as a key player in CRC’s defenses and disrupted its gene by developing an advanced oral CRISPR–Cas9 delivery system. Encased in nanocomplexes, this system navig…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Inside Precision Medicine broke the news in on Wednesday, April 23, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.